Breast cancer patients treated with alpelisib have elevated rates of high blood sugar

Breast cancer patients treated with alpelisib have elevated rates of high blood sugar

New research has uncovered elevated rates of high blood sugar, or hyperglycemia, among patients with breast cancer who are treated with the oral medication alpelisib.

Breast Cancer Drug Could Trigger Dangerous High Blood Sugar

MONDAY, Sept. 25, 2023 (HealthDay News) -- For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes

Breast cancer drug could trigger dangerous high blood sugar

For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high blood sugar levels.